How We Invest
Overview
Our Verticals
PearX
Seed
Why Pear?
Founder Services
Overview
Pear Studio
Talent Services
Fundraising
Go-To-Market Services
PR and Marketing
Programs
Overview
Dorm
Female Founder Circles
Persian Founder Circles
Resources
Featured
Events & Summits
Blog
Press
Pear Almanac
Companies
Team
PearX
PearX
Topic:
Perspectives
Pear Biotech Bench to Business: insights on ‘Designer Immune Systems,’ allogeneic stem cell therapies, and making an impact on the lives of patients with Ivan Dimov
How three PearX S19 alums raised $50M this quarter
Biotech Behemoths in Review
Pear Biotech Bench to Business: insights on identifying new cancer targets, building a discovery pipeline, and growing as a CEO with Kevin Parker
Pear Biotech Bench to Business: insights on tackling solid tumors and navigating company creation with Shelley Force Aldred
Pear portfolio company BioAge Labs announces oversubscribed $170M Series D financing
Pear Biotech Bench to Business: insights on the past, present, and future of synthetic biology with Dr. Jim Collins
Perspectives in AI with Kamil Rocki, Head of Performance Engineering at Stability AI
Pear Biotech Bench to Business: insights on generative AI in healthcare and biotech with Dr. James Zou
The vertical software data gold mine
Previous Page
1
2
Next Page